Global Antiviral Immunoglobulin Supply, Demand and Key Producers, 2026-2032
The global Antiviral Immunoglobulin market size is expected to reach $ 17924 million by 2032, rising at a market growth of 6.4% CAGR during the forecast period (2026-2032).
Antiviral immunoglobulin refers to a class of biological medicinal products containing specific antibodies used for the prevention (prophylaxis) or treatment of viral diseases, operating on the principle of passive immunization. In 2025,global antiviral immunoglobulin production reached approximately 1,731K Kg, with an average global market price of around USD 6,500 per Kg. A factory gross profit of USD 1,950 per Kg with 30% gross margin. A single line full machine capacity production is around 25K Kg per line per year.The upstream segment is highly dependent on the global human plasma supply chain. Downstream demand is concentrated in hospitals,emergency care and research and specialty clinics. A hepatitis B-positive liver transplant recipient receives HBIG therapy following transplantation to reduce the risk of viral recurrence and graft failure. China isleading due to aggressive expansion of plasma-derived biologics manufacturing, increasing healthcare expenditure, and growing domestic demand for immunotherapy products. while US following due to advanced transplant medicine, high immunoglobulin utilization rates, strong reimbursement systems, and continuous expansion of plasma donation infrastructure.
This report studies the global Antiviral Immunoglobulin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antiviral Immunoglobulin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antiviral Immunoglobulin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antiviral Immunoglobulin total production and demand, 2021-2032, (kg)
Global Antiviral Immunoglobulin total production value, 2021-2032, (USD Million)
Global Antiviral Immunoglobulin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (kg), (based on production site)
Global Antiviral Immunoglobulin consumption by region & country, CAGR, 2021-2032 & (kg)
U.S. VS China: Antiviral Immunoglobulin domestic production, consumption, key domestic manufacturers and share
Global Antiviral Immunoglobulin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (kg)
Global Antiviral Immunoglobulin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (kg)
Global Antiviral Immunoglobulin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (kg)
This report profiles key players in the global Antiviral Immunoglobulin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ADMA Biologics (US), AstraZeneca (UK/Sweden), Bharat Serums & Vaccines (India), Biotest (Germany), Boya Bio (China), China Biologic Products (CNBG) (China), CSL Behring (US/Germany), Emergent BioSolutions (US), GC Pharma (S. Korea), Grifols (Spain), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antiviral Immunoglobulin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (kg) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Antiviral Immunoglobulin Market, By Region:
1. How big is the global Antiviral Immunoglobulin market?
2. What is the demand of the global Antiviral Immunoglobulin market?
3. What is the year over year growth of the global Antiviral Immunoglobulin market?
4. What is the production and production value of the global Antiviral Immunoglobulin market?
5. Who are the key producers in the global Antiviral Immunoglobulin market?
6. What are the growth factors driving the market demand?
Antiviral immunoglobulin refers to a class of biological medicinal products containing specific antibodies used for the prevention (prophylaxis) or treatment of viral diseases, operating on the principle of passive immunization. In 2025,global antiviral immunoglobulin production reached approximately 1,731K Kg, with an average global market price of around USD 6,500 per Kg. A factory gross profit of USD 1,950 per Kg with 30% gross margin. A single line full machine capacity production is around 25K Kg per line per year.The upstream segment is highly dependent on the global human plasma supply chain. Downstream demand is concentrated in hospitals,emergency care and research and specialty clinics. A hepatitis B-positive liver transplant recipient receives HBIG therapy following transplantation to reduce the risk of viral recurrence and graft failure. China isleading due to aggressive expansion of plasma-derived biologics manufacturing, increasing healthcare expenditure, and growing domestic demand for immunotherapy products. while US following due to advanced transplant medicine, high immunoglobulin utilization rates, strong reimbursement systems, and continuous expansion of plasma donation infrastructure.
This report studies the global Antiviral Immunoglobulin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antiviral Immunoglobulin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antiviral Immunoglobulin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Antiviral Immunoglobulin total production and demand, 2021-2032, (kg)
Global Antiviral Immunoglobulin total production value, 2021-2032, (USD Million)
Global Antiviral Immunoglobulin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (kg), (based on production site)
Global Antiviral Immunoglobulin consumption by region & country, CAGR, 2021-2032 & (kg)
U.S. VS China: Antiviral Immunoglobulin domestic production, consumption, key domestic manufacturers and share
Global Antiviral Immunoglobulin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (kg)
Global Antiviral Immunoglobulin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (kg)
Global Antiviral Immunoglobulin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (kg)
This report profiles key players in the global Antiviral Immunoglobulin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ADMA Biologics (US), AstraZeneca (UK/Sweden), Bharat Serums & Vaccines (India), Biotest (Germany), Boya Bio (China), China Biologic Products (CNBG) (China), CSL Behring (US/Germany), Emergent BioSolutions (US), GC Pharma (S. Korea), Grifols (Spain), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antiviral Immunoglobulin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (kg) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Antiviral Immunoglobulin Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Human Plasma Derived Polyclonal
- Hyperimmune Specific Globulin
- Recombinant Monoclonal Antibody (mAb)
- Animal Derived (Equine/Ovine)
- Others
- Standard Fractionated Grade (90%–95%)
- Clinical High Purity Grade (96%–98%)
- Ultra Purified Specialty Grade(99%)
- Transplantation
- Infectious Disease Prophylaxis
- Immunodeficiency
- Neurology (Autoimmune)
- Others
- Hospitals
- Specialty Clinics
- Home Care
- Others
- ADMA Biologics (US)
- AstraZeneca (UK/Sweden)
- Bharat Serums & Vaccines (India)
- Biotest (Germany)
- Boya Bio (China)
- China Biologic Products (CNBG) (China)
- CSL Behring (US/Germany)
- Emergent BioSolutions (US)
- GC Pharma (S. Korea)
- Grifols (Spain)
- Hualan Biological (China)
- Intas Pharmaceuticals (India)
- Kamada (Israel)
- Kedrion (Italy)
- LFB Group (France)
- Octapharma (Switzerland)
- Regeneron (US)
- Roche (Switzerland)
- Sanofi (France)
- Shanghai RAAS (China)
- Shuanglin Bio (China)
- SK Plasma (S. Korea)
- Takeda Pharmaceutical (Japan)
- Tiantan Bio (China)
- Weiguang Biological (China)
- Yuanda Shuyang (China)
1. How big is the global Antiviral Immunoglobulin market?
2. What is the demand of the global Antiviral Immunoglobulin market?
3. What is the year over year growth of the global Antiviral Immunoglobulin market?
4. What is the production and production value of the global Antiviral Immunoglobulin market?
5. Who are the key producers in the global Antiviral Immunoglobulin market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Antiviral Immunoglobulin Introduction
1.2 World Antiviral Immunoglobulin Supply & Forecast
1.2.1 World Antiviral Immunoglobulin Production Value (2021 & 2025 & 2032)
1.2.2 World Antiviral Immunoglobulin Production (2021-2032)
1.2.3 World Antiviral Immunoglobulin Pricing Trends (2021-2032)
1.3 World Antiviral Immunoglobulin Production by Region (Based on Production Site)
1.3.1 World Antiviral Immunoglobulin Production Value by Region (2021-2032)
1.3.2 World Antiviral Immunoglobulin Production by Region (2021-2032)
1.3.3 World Antiviral Immunoglobulin Average Price by Region (2021-2032)
1.3.4 North America Antiviral Immunoglobulin Production (2021-2032)
1.3.5 Europe Antiviral Immunoglobulin Production (2021-2032)
1.3.6 China Antiviral Immunoglobulin Production (2021-2032)
1.3.7 Japan Antiviral Immunoglobulin Production (2021-2032)
1.3.8 India Antiviral Immunoglobulin Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antiviral Immunoglobulin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antiviral Immunoglobulin Major Market Trends
2 DEMAND SUMMARY
2.1 World Antiviral Immunoglobulin Demand (2021-2032)
2.2 World Antiviral Immunoglobulin Consumption by Region
2.2.1 World Antiviral Immunoglobulin Consumption by Region (2021-2026)
2.2.2 World Antiviral Immunoglobulin Consumption Forecast by Region (2027-2032)
2.3 United States Antiviral Immunoglobulin Consumption (2021-2032)
2.4 China Antiviral Immunoglobulin Consumption (2021-2032)
2.5 Europe Antiviral Immunoglobulin Consumption (2021-2032)
2.6 Japan Antiviral Immunoglobulin Consumption (2021-2032)
2.7 South Korea Antiviral Immunoglobulin Consumption (2021-2032)
2.8 ASEAN Antiviral Immunoglobulin Consumption (2021-2032)
2.9 India Antiviral Immunoglobulin Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Antiviral Immunoglobulin Production Value by Manufacturer (2021-2026)
3.2 World Antiviral Immunoglobulin Production by Manufacturer (2021-2026)
3.3 World Antiviral Immunoglobulin Average Price by Manufacturer (2021-2026)
3.4 Antiviral Immunoglobulin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Antiviral Immunoglobulin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Antiviral Immunoglobulin in 2025
3.5.3 Global Concentration Ratios (CR8) for Antiviral Immunoglobulin in 2025
3.6 Antiviral Immunoglobulin Market: Overall Company Footprint Analysis
3.6.1 Antiviral Immunoglobulin Market: Region Footprint
3.6.2 Antiviral Immunoglobulin Market: Company Product Type Footprint
3.6.3 Antiviral Immunoglobulin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Antiviral Immunoglobulin Production Value Comparison
4.1.1 United States VS China: Antiviral Immunoglobulin Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Antiviral Immunoglobulin Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Antiviral Immunoglobulin Production Comparison
4.2.1 United States VS China: Antiviral Immunoglobulin Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Antiviral Immunoglobulin Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Antiviral Immunoglobulin Consumption Comparison
4.3.1 United States VS China: Antiviral Immunoglobulin Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Antiviral Immunoglobulin Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Antiviral Immunoglobulin Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Antiviral Immunoglobulin Production Value (2021-2026)
4.4.3 United States Based Manufacturers Antiviral Immunoglobulin Production (2021-2026)
4.5 China Based Antiviral Immunoglobulin Manufacturers and Market Share
4.5.1 China Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Antiviral Immunoglobulin Production Value (2021-2026)
4.5.3 China Based Manufacturers Antiviral Immunoglobulin Production (2021-2026)
4.6 Rest of World Based Antiviral Immunoglobulin Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Antiviral Immunoglobulin Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Antiviral Immunoglobulin Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Antiviral Immunoglobulin Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Human Plasma Derived Polyclonal
5.2.2 Hyperimmune Specific Globulin
5.2.3 Recombinant Monoclonal Antibody (mAb)
5.2.4 Animal Derived (Equine/Ovine)
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Antiviral Immunoglobulin Production by Type (2021-2032)
5.3.2 World Antiviral Immunoglobulin Production Value by Type (2021-2032)
5.3.3 World Antiviral Immunoglobulin Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY IGG PURITY
6.1 World Antiviral Immunoglobulin Market Size Overview by IgG Purity: 2021 VS 2025 VS 2032
6.2 Segment Introduction by IgG Purity
6.2.1 Standard Fractionated Grade (90%–95%)
6.2.2 Clinical High Purity Grade (96%–98%)
6.2.3 Ultra Purified Specialty Grade(99%)
6.3 Market Segment by IgG Purity
6.3.1 World Antiviral Immunoglobulin Production by IgG Purity (2021-2032)
6.3.2 World Antiviral Immunoglobulin Production Value by IgG Purity (2021-2032)
6.3.3 World Antiviral Immunoglobulin Average Price by IgG Purity (2021-2032)
7 MARKET ANALYSIS BY THERAPEUTIC AREA
7.1 World Antiviral Immunoglobulin Market Size Overview by Therapeutic Area: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Therapeutic Area
7.2.1 Transplantation
7.2.2 Infectious Disease Prophylaxis
7.2.3 Immunodeficiency
7.2.4 Neurology (Autoimmune)
7.2.5 Others
7.3 Market Segment by Therapeutic Area
7.3.1 World Antiviral Immunoglobulin Production by Therapeutic Area (2021-2032)
7.3.2 World Antiviral Immunoglobulin Production Value by Therapeutic Area (2021-2032)
7.3.3 World Antiviral Immunoglobulin Average Price by Therapeutic Area (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Antiviral Immunoglobulin Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Specialty Clinics
8.2.3 Home Care
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Antiviral Immunoglobulin Production by Application (2021-2032)
8.3.2 World Antiviral Immunoglobulin Production Value by Application (2021-2032)
8.3.3 World Antiviral Immunoglobulin Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 ADMA Biologics (US)
9.1.1 ADMA Biologics (US) Details
9.1.2 ADMA Biologics (US) Major Business
9.1.3 ADMA Biologics (US) Antiviral Immunoglobulin Product and Services
9.1.4 ADMA Biologics (US) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 ADMA Biologics (US) Recent Developments/Updates
9.1.6 ADMA Biologics (US) Competitive Strengths & Weaknesses
9.2 AstraZeneca (UK/Sweden)
9.2.1 AstraZeneca (UK/Sweden) Details
9.2.2 AstraZeneca (UK/Sweden) Major Business
9.2.3 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Product and Services
9.2.4 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 AstraZeneca (UK/Sweden) Recent Developments/Updates
9.2.6 AstraZeneca (UK/Sweden) Competitive Strengths & Weaknesses
9.3 Bharat Serums & Vaccines (India)
9.3.1 Bharat Serums & Vaccines (India) Details
9.3.2 Bharat Serums & Vaccines (India) Major Business
9.3.3 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Product and Services
9.3.4 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bharat Serums & Vaccines (India) Recent Developments/Updates
9.3.6 Bharat Serums & Vaccines (India) Competitive Strengths & Weaknesses
9.4 Biotest (Germany)
9.4.1 Biotest (Germany) Details
9.4.2 Biotest (Germany) Major Business
9.4.3 Biotest (Germany) Antiviral Immunoglobulin Product and Services
9.4.4 Biotest (Germany) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Biotest (Germany) Recent Developments/Updates
9.4.6 Biotest (Germany) Competitive Strengths & Weaknesses
9.5 Boya Bio (China)
9.5.1 Boya Bio (China) Details
9.5.2 Boya Bio (China) Major Business
9.5.3 Boya Bio (China) Antiviral Immunoglobulin Product and Services
9.5.4 Boya Bio (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Boya Bio (China) Recent Developments/Updates
9.5.6 Boya Bio (China) Competitive Strengths & Weaknesses
9.6 China Biologic Products (CNBG) (China)
9.6.1 China Biologic Products (CNBG) (China) Details
9.6.2 China Biologic Products (CNBG) (China) Major Business
9.6.3 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Product and Services
9.6.4 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 China Biologic Products (CNBG) (China) Recent Developments/Updates
9.6.6 China Biologic Products (CNBG) (China) Competitive Strengths & Weaknesses
9.7 CSL Behring (US/Germany)
9.7.1 CSL Behring (US/Germany) Details
9.7.2 CSL Behring (US/Germany) Major Business
9.7.3 CSL Behring (US/Germany) Antiviral Immunoglobulin Product and Services
9.7.4 CSL Behring (US/Germany) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 CSL Behring (US/Germany) Recent Developments/Updates
9.7.6 CSL Behring (US/Germany) Competitive Strengths & Weaknesses
9.8 Emergent BioSolutions (US)
9.8.1 Emergent BioSolutions (US) Details
9.8.2 Emergent BioSolutions (US) Major Business
9.8.3 Emergent BioSolutions (US) Antiviral Immunoglobulin Product and Services
9.8.4 Emergent BioSolutions (US) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Emergent BioSolutions (US) Recent Developments/Updates
9.8.6 Emergent BioSolutions (US) Competitive Strengths & Weaknesses
9.9 GC Pharma (S. Korea)
9.9.1 GC Pharma (S. Korea) Details
9.9.2 GC Pharma (S. Korea) Major Business
9.9.3 GC Pharma (S. Korea) Antiviral Immunoglobulin Product and Services
9.9.4 GC Pharma (S. Korea) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 GC Pharma (S. Korea) Recent Developments/Updates
9.9.6 GC Pharma (S. Korea) Competitive Strengths & Weaknesses
9.10 Grifols (Spain)
9.10.1 Grifols (Spain) Details
9.10.2 Grifols (Spain) Major Business
9.10.3 Grifols (Spain) Antiviral Immunoglobulin Product and Services
9.10.4 Grifols (Spain) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Grifols (Spain) Recent Developments/Updates
9.10.6 Grifols (Spain) Competitive Strengths & Weaknesses
9.11 Hualan Biological (China)
9.11.1 Hualan Biological (China) Details
9.11.2 Hualan Biological (China) Major Business
9.11.3 Hualan Biological (China) Antiviral Immunoglobulin Product and Services
9.11.4 Hualan Biological (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Hualan Biological (China) Recent Developments/Updates
9.11.6 Hualan Biological (China) Competitive Strengths & Weaknesses
9.12 Intas Pharmaceuticals (India)
9.12.1 Intas Pharmaceuticals (India) Details
9.12.2 Intas Pharmaceuticals (India) Major Business
9.12.3 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Product and Services
9.12.4 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Intas Pharmaceuticals (India) Recent Developments/Updates
9.12.6 Intas Pharmaceuticals (India) Competitive Strengths & Weaknesses
9.13 Kamada (Israel)
9.13.1 Kamada (Israel) Details
9.13.2 Kamada (Israel) Major Business
9.13.3 Kamada (Israel) Antiviral Immunoglobulin Product and Services
9.13.4 Kamada (Israel) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Kamada (Israel) Recent Developments/Updates
9.13.6 Kamada (Israel) Competitive Strengths & Weaknesses
9.14 Kedrion (Italy)
9.14.1 Kedrion (Italy) Details
9.14.2 Kedrion (Italy) Major Business
9.14.3 Kedrion (Italy) Antiviral Immunoglobulin Product and Services
9.14.4 Kedrion (Italy) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Kedrion (Italy) Recent Developments/Updates
9.14.6 Kedrion (Italy) Competitive Strengths & Weaknesses
9.15 LFB Group (France)
9.15.1 LFB Group (France) Details
9.15.2 LFB Group (France) Major Business
9.15.3 LFB Group (France) Antiviral Immunoglobulin Product and Services
9.15.4 LFB Group (France) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 LFB Group (France) Recent Developments/Updates
9.15.6 LFB Group (France) Competitive Strengths & Weaknesses
9.16 Octapharma (Switzerland)
9.16.1 Octapharma (Switzerland) Details
9.16.2 Octapharma (Switzerland) Major Business
9.16.3 Octapharma (Switzerland) Antiviral Immunoglobulin Product and Services
9.16.4 Octapharma (Switzerland) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Octapharma (Switzerland) Recent Developments/Updates
9.16.6 Octapharma (Switzerland) Competitive Strengths & Weaknesses
9.17 Regeneron (US)
9.17.1 Regeneron (US) Details
9.17.2 Regeneron (US) Major Business
9.17.3 Regeneron (US) Antiviral Immunoglobulin Product and Services
9.17.4 Regeneron (US) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Regeneron (US) Recent Developments/Updates
9.17.6 Regeneron (US) Competitive Strengths & Weaknesses
9.18 Roche (Switzerland)
9.18.1 Roche (Switzerland) Details
9.18.2 Roche (Switzerland) Major Business
9.18.3 Roche (Switzerland) Antiviral Immunoglobulin Product and Services
9.18.4 Roche (Switzerland) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Roche (Switzerland) Recent Developments/Updates
9.18.6 Roche (Switzerland) Competitive Strengths & Weaknesses
9.19 Sanofi (France)
9.19.1 Sanofi (France) Details
9.19.2 Sanofi (France) Major Business
9.19.3 Sanofi (France) Antiviral Immunoglobulin Product and Services
9.19.4 Sanofi (France) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Sanofi (France) Recent Developments/Updates
9.19.6 Sanofi (France) Competitive Strengths & Weaknesses
9.20 Shanghai RAAS (China)
9.20.1 Shanghai RAAS (China) Details
9.20.2 Shanghai RAAS (China) Major Business
9.20.3 Shanghai RAAS (China) Antiviral Immunoglobulin Product and Services
9.20.4 Shanghai RAAS (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Shanghai RAAS (China) Recent Developments/Updates
9.20.6 Shanghai RAAS (China) Competitive Strengths & Weaknesses
9.21 Shuanglin Bio (China)
9.21.1 Shuanglin Bio (China) Details
9.21.2 Shuanglin Bio (China) Major Business
9.21.3 Shuanglin Bio (China) Antiviral Immunoglobulin Product and Services
9.21.4 Shuanglin Bio (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Shuanglin Bio (China) Recent Developments/Updates
9.21.6 Shuanglin Bio (China) Competitive Strengths & Weaknesses
9.22 SK Plasma (S. Korea)
9.22.1 SK Plasma (S. Korea) Details
9.22.2 SK Plasma (S. Korea) Major Business
9.22.3 SK Plasma (S. Korea) Antiviral Immunoglobulin Product and Services
9.22.4 SK Plasma (S. Korea) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 SK Plasma (S. Korea) Recent Developments/Updates
9.22.6 SK Plasma (S. Korea) Competitive Strengths & Weaknesses
9.23 Takeda Pharmaceutical (Japan)
9.23.1 Takeda Pharmaceutical (Japan) Details
9.23.2 Takeda Pharmaceutical (Japan) Major Business
9.23.3 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Product and Services
9.23.4 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Takeda Pharmaceutical (Japan) Recent Developments/Updates
9.23.6 Takeda Pharmaceutical (Japan) Competitive Strengths & Weaknesses
9.24 Tiantan Bio (China)
9.24.1 Tiantan Bio (China) Details
9.24.2 Tiantan Bio (China) Major Business
9.24.3 Tiantan Bio (China) Antiviral Immunoglobulin Product and Services
9.24.4 Tiantan Bio (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Tiantan Bio (China) Recent Developments/Updates
9.24.6 Tiantan Bio (China) Competitive Strengths & Weaknesses
9.25 Weiguang Biological (China)
9.25.1 Weiguang Biological (China) Details
9.25.2 Weiguang Biological (China) Major Business
9.25.3 Weiguang Biological (China) Antiviral Immunoglobulin Product and Services
9.25.4 Weiguang Biological (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 Weiguang Biological (China) Recent Developments/Updates
9.25.6 Weiguang Biological (China) Competitive Strengths & Weaknesses
9.26 Yuanda Shuyang (China)
9.26.1 Yuanda Shuyang (China) Details
9.26.2 Yuanda Shuyang (China) Major Business
9.26.3 Yuanda Shuyang (China) Antiviral Immunoglobulin Product and Services
9.26.4 Yuanda Shuyang (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Yuanda Shuyang (China) Recent Developments/Updates
9.26.6 Yuanda Shuyang (China) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Antiviral Immunoglobulin Industry Chain
10.2 Antiviral Immunoglobulin Upstream Analysis
10.2.1 Antiviral Immunoglobulin Core Raw Materials
10.2.2 Main Manufacturers of Antiviral Immunoglobulin Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Antiviral Immunoglobulin Production Mode
10.6 Antiviral Immunoglobulin Procurement Model
10.7 Antiviral Immunoglobulin Industry Sales Model and Sales Channels
10.7.1 Antiviral Immunoglobulin Sales Model
10.7.2 Antiviral Immunoglobulin Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Antiviral Immunoglobulin Introduction
1.2 World Antiviral Immunoglobulin Supply & Forecast
1.2.1 World Antiviral Immunoglobulin Production Value (2021 & 2025 & 2032)
1.2.2 World Antiviral Immunoglobulin Production (2021-2032)
1.2.3 World Antiviral Immunoglobulin Pricing Trends (2021-2032)
1.3 World Antiviral Immunoglobulin Production by Region (Based on Production Site)
1.3.1 World Antiviral Immunoglobulin Production Value by Region (2021-2032)
1.3.2 World Antiviral Immunoglobulin Production by Region (2021-2032)
1.3.3 World Antiviral Immunoglobulin Average Price by Region (2021-2032)
1.3.4 North America Antiviral Immunoglobulin Production (2021-2032)
1.3.5 Europe Antiviral Immunoglobulin Production (2021-2032)
1.3.6 China Antiviral Immunoglobulin Production (2021-2032)
1.3.7 Japan Antiviral Immunoglobulin Production (2021-2032)
1.3.8 India Antiviral Immunoglobulin Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antiviral Immunoglobulin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antiviral Immunoglobulin Major Market Trends
2 DEMAND SUMMARY
2.1 World Antiviral Immunoglobulin Demand (2021-2032)
2.2 World Antiviral Immunoglobulin Consumption by Region
2.2.1 World Antiviral Immunoglobulin Consumption by Region (2021-2026)
2.2.2 World Antiviral Immunoglobulin Consumption Forecast by Region (2027-2032)
2.3 United States Antiviral Immunoglobulin Consumption (2021-2032)
2.4 China Antiviral Immunoglobulin Consumption (2021-2032)
2.5 Europe Antiviral Immunoglobulin Consumption (2021-2032)
2.6 Japan Antiviral Immunoglobulin Consumption (2021-2032)
2.7 South Korea Antiviral Immunoglobulin Consumption (2021-2032)
2.8 ASEAN Antiviral Immunoglobulin Consumption (2021-2032)
2.9 India Antiviral Immunoglobulin Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Antiviral Immunoglobulin Production Value by Manufacturer (2021-2026)
3.2 World Antiviral Immunoglobulin Production by Manufacturer (2021-2026)
3.3 World Antiviral Immunoglobulin Average Price by Manufacturer (2021-2026)
3.4 Antiviral Immunoglobulin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Antiviral Immunoglobulin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Antiviral Immunoglobulin in 2025
3.5.3 Global Concentration Ratios (CR8) for Antiviral Immunoglobulin in 2025
3.6 Antiviral Immunoglobulin Market: Overall Company Footprint Analysis
3.6.1 Antiviral Immunoglobulin Market: Region Footprint
3.6.2 Antiviral Immunoglobulin Market: Company Product Type Footprint
3.6.3 Antiviral Immunoglobulin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Antiviral Immunoglobulin Production Value Comparison
4.1.1 United States VS China: Antiviral Immunoglobulin Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Antiviral Immunoglobulin Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Antiviral Immunoglobulin Production Comparison
4.2.1 United States VS China: Antiviral Immunoglobulin Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Antiviral Immunoglobulin Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Antiviral Immunoglobulin Consumption Comparison
4.3.1 United States VS China: Antiviral Immunoglobulin Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Antiviral Immunoglobulin Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Antiviral Immunoglobulin Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Antiviral Immunoglobulin Production Value (2021-2026)
4.4.3 United States Based Manufacturers Antiviral Immunoglobulin Production (2021-2026)
4.5 China Based Antiviral Immunoglobulin Manufacturers and Market Share
4.5.1 China Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Antiviral Immunoglobulin Production Value (2021-2026)
4.5.3 China Based Manufacturers Antiviral Immunoglobulin Production (2021-2026)
4.6 Rest of World Based Antiviral Immunoglobulin Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Antiviral Immunoglobulin Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Antiviral Immunoglobulin Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Antiviral Immunoglobulin Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Human Plasma Derived Polyclonal
5.2.2 Hyperimmune Specific Globulin
5.2.3 Recombinant Monoclonal Antibody (mAb)
5.2.4 Animal Derived (Equine/Ovine)
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Antiviral Immunoglobulin Production by Type (2021-2032)
5.3.2 World Antiviral Immunoglobulin Production Value by Type (2021-2032)
5.3.3 World Antiviral Immunoglobulin Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY IGG PURITY
6.1 World Antiviral Immunoglobulin Market Size Overview by IgG Purity: 2021 VS 2025 VS 2032
6.2 Segment Introduction by IgG Purity
6.2.1 Standard Fractionated Grade (90%–95%)
6.2.2 Clinical High Purity Grade (96%–98%)
6.2.3 Ultra Purified Specialty Grade(99%)
6.3 Market Segment by IgG Purity
6.3.1 World Antiviral Immunoglobulin Production by IgG Purity (2021-2032)
6.3.2 World Antiviral Immunoglobulin Production Value by IgG Purity (2021-2032)
6.3.3 World Antiviral Immunoglobulin Average Price by IgG Purity (2021-2032)
7 MARKET ANALYSIS BY THERAPEUTIC AREA
7.1 World Antiviral Immunoglobulin Market Size Overview by Therapeutic Area: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Therapeutic Area
7.2.1 Transplantation
7.2.2 Infectious Disease Prophylaxis
7.2.3 Immunodeficiency
7.2.4 Neurology (Autoimmune)
7.2.5 Others
7.3 Market Segment by Therapeutic Area
7.3.1 World Antiviral Immunoglobulin Production by Therapeutic Area (2021-2032)
7.3.2 World Antiviral Immunoglobulin Production Value by Therapeutic Area (2021-2032)
7.3.3 World Antiviral Immunoglobulin Average Price by Therapeutic Area (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Antiviral Immunoglobulin Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Specialty Clinics
8.2.3 Home Care
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Antiviral Immunoglobulin Production by Application (2021-2032)
8.3.2 World Antiviral Immunoglobulin Production Value by Application (2021-2032)
8.3.3 World Antiviral Immunoglobulin Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 ADMA Biologics (US)
9.1.1 ADMA Biologics (US) Details
9.1.2 ADMA Biologics (US) Major Business
9.1.3 ADMA Biologics (US) Antiviral Immunoglobulin Product and Services
9.1.4 ADMA Biologics (US) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 ADMA Biologics (US) Recent Developments/Updates
9.1.6 ADMA Biologics (US) Competitive Strengths & Weaknesses
9.2 AstraZeneca (UK/Sweden)
9.2.1 AstraZeneca (UK/Sweden) Details
9.2.2 AstraZeneca (UK/Sweden) Major Business
9.2.3 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Product and Services
9.2.4 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 AstraZeneca (UK/Sweden) Recent Developments/Updates
9.2.6 AstraZeneca (UK/Sweden) Competitive Strengths & Weaknesses
9.3 Bharat Serums & Vaccines (India)
9.3.1 Bharat Serums & Vaccines (India) Details
9.3.2 Bharat Serums & Vaccines (India) Major Business
9.3.3 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Product and Services
9.3.4 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bharat Serums & Vaccines (India) Recent Developments/Updates
9.3.6 Bharat Serums & Vaccines (India) Competitive Strengths & Weaknesses
9.4 Biotest (Germany)
9.4.1 Biotest (Germany) Details
9.4.2 Biotest (Germany) Major Business
9.4.3 Biotest (Germany) Antiviral Immunoglobulin Product and Services
9.4.4 Biotest (Germany) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Biotest (Germany) Recent Developments/Updates
9.4.6 Biotest (Germany) Competitive Strengths & Weaknesses
9.5 Boya Bio (China)
9.5.1 Boya Bio (China) Details
9.5.2 Boya Bio (China) Major Business
9.5.3 Boya Bio (China) Antiviral Immunoglobulin Product and Services
9.5.4 Boya Bio (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Boya Bio (China) Recent Developments/Updates
9.5.6 Boya Bio (China) Competitive Strengths & Weaknesses
9.6 China Biologic Products (CNBG) (China)
9.6.1 China Biologic Products (CNBG) (China) Details
9.6.2 China Biologic Products (CNBG) (China) Major Business
9.6.3 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Product and Services
9.6.4 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 China Biologic Products (CNBG) (China) Recent Developments/Updates
9.6.6 China Biologic Products (CNBG) (China) Competitive Strengths & Weaknesses
9.7 CSL Behring (US/Germany)
9.7.1 CSL Behring (US/Germany) Details
9.7.2 CSL Behring (US/Germany) Major Business
9.7.3 CSL Behring (US/Germany) Antiviral Immunoglobulin Product and Services
9.7.4 CSL Behring (US/Germany) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 CSL Behring (US/Germany) Recent Developments/Updates
9.7.6 CSL Behring (US/Germany) Competitive Strengths & Weaknesses
9.8 Emergent BioSolutions (US)
9.8.1 Emergent BioSolutions (US) Details
9.8.2 Emergent BioSolutions (US) Major Business
9.8.3 Emergent BioSolutions (US) Antiviral Immunoglobulin Product and Services
9.8.4 Emergent BioSolutions (US) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Emergent BioSolutions (US) Recent Developments/Updates
9.8.6 Emergent BioSolutions (US) Competitive Strengths & Weaknesses
9.9 GC Pharma (S. Korea)
9.9.1 GC Pharma (S. Korea) Details
9.9.2 GC Pharma (S. Korea) Major Business
9.9.3 GC Pharma (S. Korea) Antiviral Immunoglobulin Product and Services
9.9.4 GC Pharma (S. Korea) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 GC Pharma (S. Korea) Recent Developments/Updates
9.9.6 GC Pharma (S. Korea) Competitive Strengths & Weaknesses
9.10 Grifols (Spain)
9.10.1 Grifols (Spain) Details
9.10.2 Grifols (Spain) Major Business
9.10.3 Grifols (Spain) Antiviral Immunoglobulin Product and Services
9.10.4 Grifols (Spain) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Grifols (Spain) Recent Developments/Updates
9.10.6 Grifols (Spain) Competitive Strengths & Weaknesses
9.11 Hualan Biological (China)
9.11.1 Hualan Biological (China) Details
9.11.2 Hualan Biological (China) Major Business
9.11.3 Hualan Biological (China) Antiviral Immunoglobulin Product and Services
9.11.4 Hualan Biological (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Hualan Biological (China) Recent Developments/Updates
9.11.6 Hualan Biological (China) Competitive Strengths & Weaknesses
9.12 Intas Pharmaceuticals (India)
9.12.1 Intas Pharmaceuticals (India) Details
9.12.2 Intas Pharmaceuticals (India) Major Business
9.12.3 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Product and Services
9.12.4 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Intas Pharmaceuticals (India) Recent Developments/Updates
9.12.6 Intas Pharmaceuticals (India) Competitive Strengths & Weaknesses
9.13 Kamada (Israel)
9.13.1 Kamada (Israel) Details
9.13.2 Kamada (Israel) Major Business
9.13.3 Kamada (Israel) Antiviral Immunoglobulin Product and Services
9.13.4 Kamada (Israel) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Kamada (Israel) Recent Developments/Updates
9.13.6 Kamada (Israel) Competitive Strengths & Weaknesses
9.14 Kedrion (Italy)
9.14.1 Kedrion (Italy) Details
9.14.2 Kedrion (Italy) Major Business
9.14.3 Kedrion (Italy) Antiviral Immunoglobulin Product and Services
9.14.4 Kedrion (Italy) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Kedrion (Italy) Recent Developments/Updates
9.14.6 Kedrion (Italy) Competitive Strengths & Weaknesses
9.15 LFB Group (France)
9.15.1 LFB Group (France) Details
9.15.2 LFB Group (France) Major Business
9.15.3 LFB Group (France) Antiviral Immunoglobulin Product and Services
9.15.4 LFB Group (France) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 LFB Group (France) Recent Developments/Updates
9.15.6 LFB Group (France) Competitive Strengths & Weaknesses
9.16 Octapharma (Switzerland)
9.16.1 Octapharma (Switzerland) Details
9.16.2 Octapharma (Switzerland) Major Business
9.16.3 Octapharma (Switzerland) Antiviral Immunoglobulin Product and Services
9.16.4 Octapharma (Switzerland) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Octapharma (Switzerland) Recent Developments/Updates
9.16.6 Octapharma (Switzerland) Competitive Strengths & Weaknesses
9.17 Regeneron (US)
9.17.1 Regeneron (US) Details
9.17.2 Regeneron (US) Major Business
9.17.3 Regeneron (US) Antiviral Immunoglobulin Product and Services
9.17.4 Regeneron (US) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Regeneron (US) Recent Developments/Updates
9.17.6 Regeneron (US) Competitive Strengths & Weaknesses
9.18 Roche (Switzerland)
9.18.1 Roche (Switzerland) Details
9.18.2 Roche (Switzerland) Major Business
9.18.3 Roche (Switzerland) Antiviral Immunoglobulin Product and Services
9.18.4 Roche (Switzerland) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Roche (Switzerland) Recent Developments/Updates
9.18.6 Roche (Switzerland) Competitive Strengths & Weaknesses
9.19 Sanofi (France)
9.19.1 Sanofi (France) Details
9.19.2 Sanofi (France) Major Business
9.19.3 Sanofi (France) Antiviral Immunoglobulin Product and Services
9.19.4 Sanofi (France) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Sanofi (France) Recent Developments/Updates
9.19.6 Sanofi (France) Competitive Strengths & Weaknesses
9.20 Shanghai RAAS (China)
9.20.1 Shanghai RAAS (China) Details
9.20.2 Shanghai RAAS (China) Major Business
9.20.3 Shanghai RAAS (China) Antiviral Immunoglobulin Product and Services
9.20.4 Shanghai RAAS (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Shanghai RAAS (China) Recent Developments/Updates
9.20.6 Shanghai RAAS (China) Competitive Strengths & Weaknesses
9.21 Shuanglin Bio (China)
9.21.1 Shuanglin Bio (China) Details
9.21.2 Shuanglin Bio (China) Major Business
9.21.3 Shuanglin Bio (China) Antiviral Immunoglobulin Product and Services
9.21.4 Shuanglin Bio (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 Shuanglin Bio (China) Recent Developments/Updates
9.21.6 Shuanglin Bio (China) Competitive Strengths & Weaknesses
9.22 SK Plasma (S. Korea)
9.22.1 SK Plasma (S. Korea) Details
9.22.2 SK Plasma (S. Korea) Major Business
9.22.3 SK Plasma (S. Korea) Antiviral Immunoglobulin Product and Services
9.22.4 SK Plasma (S. Korea) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 SK Plasma (S. Korea) Recent Developments/Updates
9.22.6 SK Plasma (S. Korea) Competitive Strengths & Weaknesses
9.23 Takeda Pharmaceutical (Japan)
9.23.1 Takeda Pharmaceutical (Japan) Details
9.23.2 Takeda Pharmaceutical (Japan) Major Business
9.23.3 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Product and Services
9.23.4 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Takeda Pharmaceutical (Japan) Recent Developments/Updates
9.23.6 Takeda Pharmaceutical (Japan) Competitive Strengths & Weaknesses
9.24 Tiantan Bio (China)
9.24.1 Tiantan Bio (China) Details
9.24.2 Tiantan Bio (China) Major Business
9.24.3 Tiantan Bio (China) Antiviral Immunoglobulin Product and Services
9.24.4 Tiantan Bio (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 Tiantan Bio (China) Recent Developments/Updates
9.24.6 Tiantan Bio (China) Competitive Strengths & Weaknesses
9.25 Weiguang Biological (China)
9.25.1 Weiguang Biological (China) Details
9.25.2 Weiguang Biological (China) Major Business
9.25.3 Weiguang Biological (China) Antiviral Immunoglobulin Product and Services
9.25.4 Weiguang Biological (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 Weiguang Biological (China) Recent Developments/Updates
9.25.6 Weiguang Biological (China) Competitive Strengths & Weaknesses
9.26 Yuanda Shuyang (China)
9.26.1 Yuanda Shuyang (China) Details
9.26.2 Yuanda Shuyang (China) Major Business
9.26.3 Yuanda Shuyang (China) Antiviral Immunoglobulin Product and Services
9.26.4 Yuanda Shuyang (China) Antiviral Immunoglobulin Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Yuanda Shuyang (China) Recent Developments/Updates
9.26.6 Yuanda Shuyang (China) Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Antiviral Immunoglobulin Industry Chain
10.2 Antiviral Immunoglobulin Upstream Analysis
10.2.1 Antiviral Immunoglobulin Core Raw Materials
10.2.2 Main Manufacturers of Antiviral Immunoglobulin Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Antiviral Immunoglobulin Production Mode
10.6 Antiviral Immunoglobulin Procurement Model
10.7 Antiviral Immunoglobulin Industry Sales Model and Sales Channels
10.7.1 Antiviral Immunoglobulin Sales Model
10.7.2 Antiviral Immunoglobulin Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Antiviral Immunoglobulin Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Antiviral Immunoglobulin Production Value by Region (2021-2026) & (USD Million)
Table 3. World Antiviral Immunoglobulin Production Value by Region (2027-2032) & (USD Million)
Table 4. World Antiviral Immunoglobulin Production Value Market Share by Region (2021-2026)
Table 5. World Antiviral Immunoglobulin Production Value Market Share by Region (2027-2032)
Table 6. World Antiviral Immunoglobulin Production by Region (2021-2026) & (kg)
Table 7. World Antiviral Immunoglobulin Production by Region (2027-2032) & (kg)
Table 8. World Antiviral Immunoglobulin Production Market Share by Region (2021-2026)
Table 9. World Antiviral Immunoglobulin Production Market Share by Region (2027-2032)
Table 10. World Antiviral Immunoglobulin Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Antiviral Immunoglobulin Average Price by Region (2027-2032) & (US$/kg)
Table 12. Antiviral Immunoglobulin Major Market Trends
Table 13. World Antiviral Immunoglobulin Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (kg)
Table 14. World Antiviral Immunoglobulin Consumption by Region (2021-2026) & (kg)
Table 15. World Antiviral Immunoglobulin Consumption Forecast by Region (2027-2032) & (kg)
Table 16. World Antiviral Immunoglobulin Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Antiviral Immunoglobulin Producers in 2025
Table 18. World Antiviral Immunoglobulin Production by Manufacturer (2021-2026) & (kg)
Table 19. Production Market Share of Key Antiviral Immunoglobulin Producers in 2025
Table 20. World Antiviral Immunoglobulin Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Antiviral Immunoglobulin Company Evaluation Quadrant
Table 22. World Antiviral Immunoglobulin Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Antiviral Immunoglobulin Production Site of Key Manufacturer
Table 24. Antiviral Immunoglobulin Market: Company Product Type Footprint
Table 25. Antiviral Immunoglobulin Market: Company Product Application Footprint
Table 26. Antiviral Immunoglobulin Competitive Factors
Table 27. Antiviral Immunoglobulin New Entrant and Capacity Expansion Plans
Table 28. Antiviral Immunoglobulin Mergers & Acquisitions Activity
Table 29. United States VS China Antiviral Immunoglobulin Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Antiviral Immunoglobulin Production Comparison, (2021 & 2025 & 2032) & (kg)
Table 31. United States VS China Antiviral Immunoglobulin Consumption Comparison, (2021 & 2025 & 2032) & (kg)
Table 32. United States Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Antiviral Immunoglobulin Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Antiviral Immunoglobulin Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Antiviral Immunoglobulin Production (2021-2026) & (kg)
Table 36. United States Based Manufacturers Antiviral Immunoglobulin Production Market Share (2021-2026)
Table 37. China Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Antiviral Immunoglobulin Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Antiviral Immunoglobulin Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Antiviral Immunoglobulin Production, (2021-2026) & (kg)
Table 41. China Based Manufacturers Antiviral Immunoglobulin Production Market Share (2021-2026)
Table 42. Rest of World Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Antiviral Immunoglobulin Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Antiviral Immunoglobulin Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Antiviral Immunoglobulin Production, (2021-2026) & (kg)
Table 46. Rest of World Based Manufacturers Antiviral Immunoglobulin Production Market Share (2021-2026)
Table 47. World Antiviral Immunoglobulin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Antiviral Immunoglobulin Production by Type (2021-2026) & (kg)
Table 49. World Antiviral Immunoglobulin Production by Type (2027-2032) & (kg)
Table 50. World Antiviral Immunoglobulin Production Value by Type (2021-2026) & (USD Million)
Table 51. World Antiviral Immunoglobulin Production Value by Type (2027-2032) & (USD Million)
Table 52. World Antiviral Immunoglobulin Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Antiviral Immunoglobulin Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Antiviral Immunoglobulin Production Value by IgG Purity, (USD Million), 2021 & 2025 & 2032
Table 55. World Antiviral Immunoglobulin Production by IgG Purity (2021-2026) & (kg)
Table 56. World Antiviral Immunoglobulin Production by IgG Purity (2027-2032) & (kg)
Table 57. World Antiviral Immunoglobulin Production Value by IgG Purity (2021-2026) & (USD Million)
Table 58. World Antiviral Immunoglobulin Production Value by IgG Purity (2027-2032) & (USD Million)
Table 59. World Antiviral Immunoglobulin Average Price by IgG Purity (2021-2026) & (US$/kg)
Table 60. World Antiviral Immunoglobulin Average Price by IgG Purity (2027-2032) & (US$/kg)
Table 61. World Antiviral Immunoglobulin Production Value by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Table 62. World Antiviral Immunoglobulin Production by Therapeutic Area (2021-2026) & (kg)
Table 63. World Antiviral Immunoglobulin Production by Therapeutic Area (2027-2032) & (kg)
Table 64. World Antiviral Immunoglobulin Production Value by Therapeutic Area (2021-2026) & (USD Million)
Table 65. World Antiviral Immunoglobulin Production Value by Therapeutic Area (2027-2032) & (USD Million)
Table 66. World Antiviral Immunoglobulin Average Price by Therapeutic Area (2021-2026) & (US$/kg)
Table 67. World Antiviral Immunoglobulin Average Price by Therapeutic Area (2027-2032) & (US$/kg)
Table 68. World Antiviral Immunoglobulin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Antiviral Immunoglobulin Production by Application (2021-2026) & (kg)
Table 70. World Antiviral Immunoglobulin Production by Application (2027-2032) & (kg)
Table 71. World Antiviral Immunoglobulin Production Value by Application (2021-2026) & (USD Million)
Table 72. World Antiviral Immunoglobulin Production Value by Application (2027-2032) & (USD Million)
Table 73. World Antiviral Immunoglobulin Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Antiviral Immunoglobulin Average Price by Application (2027-2032) & (US$/kg)
Table 75. ADMA Biologics (US) Basic Information, Manufacturing Base and Competitors
Table 76. ADMA Biologics (US) Major Business
Table 77. ADMA Biologics (US) Antiviral Immunoglobulin Product and Services
Table 78. ADMA Biologics (US) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. ADMA Biologics (US) Recent Developments/Updates
Table 80. ADMA Biologics (US) Competitive Strengths & Weaknesses
Table 81. AstraZeneca (UK/Sweden) Basic Information, Manufacturing Base and Competitors
Table 82. AstraZeneca (UK/Sweden) Major Business
Table 83. AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Product and Services
Table 84. AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. AstraZeneca (UK/Sweden) Recent Developments/Updates
Table 86. AstraZeneca (UK/Sweden) Competitive Strengths & Weaknesses
Table 87. Bharat Serums & Vaccines (India) Basic Information, Manufacturing Base and Competitors
Table 88. Bharat Serums & Vaccines (India) Major Business
Table 89. Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Product and Services
Table 90. Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bharat Serums & Vaccines (India) Recent Developments/Updates
Table 92. Bharat Serums & Vaccines (India) Competitive Strengths & Weaknesses
Table 93. Biotest (Germany) Basic Information, Manufacturing Base and Competitors
Table 94. Biotest (Germany) Major Business
Table 95. Biotest (Germany) Antiviral Immunoglobulin Product and Services
Table 96. Biotest (Germany) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Biotest (Germany) Recent Developments/Updates
Table 98. Biotest (Germany) Competitive Strengths & Weaknesses
Table 99. Boya Bio (China) Basic Information, Manufacturing Base and Competitors
Table 100. Boya Bio (China) Major Business
Table 101. Boya Bio (China) Antiviral Immunoglobulin Product and Services
Table 102. Boya Bio (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Boya Bio (China) Recent Developments/Updates
Table 104. Boya Bio (China) Competitive Strengths & Weaknesses
Table 105. China Biologic Products (CNBG) (China) Basic Information, Manufacturing Base and Competitors
Table 106. China Biologic Products (CNBG) (China) Major Business
Table 107. China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Product and Services
Table 108. China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. China Biologic Products (CNBG) (China) Recent Developments/Updates
Table 110. China Biologic Products (CNBG) (China) Competitive Strengths & Weaknesses
Table 111. CSL Behring (US/Germany) Basic Information, Manufacturing Base and Competitors
Table 112. CSL Behring (US/Germany) Major Business
Table 113. CSL Behring (US/Germany) Antiviral Immunoglobulin Product and Services
Table 114. CSL Behring (US/Germany) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. CSL Behring (US/Germany) Recent Developments/Updates
Table 116. CSL Behring (US/Germany) Competitive Strengths & Weaknesses
Table 117. Emergent BioSolutions (US) Basic Information, Manufacturing Base and Competitors
Table 118. Emergent BioSolutions (US) Major Business
Table 119. Emergent BioSolutions (US) Antiviral Immunoglobulin Product and Services
Table 120. Emergent BioSolutions (US) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Emergent BioSolutions (US) Recent Developments/Updates
Table 122. Emergent BioSolutions (US) Competitive Strengths & Weaknesses
Table 123. GC Pharma (S. Korea) Basic Information, Manufacturing Base and Competitors
Table 124. GC Pharma (S. Korea) Major Business
Table 125. GC Pharma (S. Korea) Antiviral Immunoglobulin Product and Services
Table 126. GC Pharma (S. Korea) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. GC Pharma (S. Korea) Recent Developments/Updates
Table 128. GC Pharma (S. Korea) Competitive Strengths & Weaknesses
Table 129. Grifols (Spain) Basic Information, Manufacturing Base and Competitors
Table 130. Grifols (Spain) Major Business
Table 131. Grifols (Spain) Antiviral Immunoglobulin Product and Services
Table 132. Grifols (Spain) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Grifols (Spain) Recent Developments/Updates
Table 134. Grifols (Spain) Competitive Strengths & Weaknesses
Table 135. Hualan Biological (China) Basic Information, Manufacturing Base and Competitors
Table 136. Hualan Biological (China) Major Business
Table 137. Hualan Biological (China) Antiviral Immunoglobulin Product and Services
Table 138. Hualan Biological (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Hualan Biological (China) Recent Developments/Updates
Table 140. Hualan Biological (China) Competitive Strengths & Weaknesses
Table 141. Intas Pharmaceuticals (India) Basic Information, Manufacturing Base and Competitors
Table 142. Intas Pharmaceuticals (India) Major Business
Table 143. Intas Pharmaceuticals (India) Antiviral Immunoglobulin Product and Services
Table 144. Intas Pharmaceuticals (India) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Intas Pharmaceuticals (India) Recent Developments/Updates
Table 146. Intas Pharmaceuticals (India) Competitive Strengths & Weaknesses
Table 147. Kamada (Israel) Basic Information, Manufacturing Base and Competitors
Table 148. Kamada (Israel) Major Business
Table 149. Kamada (Israel) Antiviral Immunoglobulin Product and Services
Table 150. Kamada (Israel) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Kamada (Israel) Recent Developments/Updates
Table 152. Kamada (Israel) Competitive Strengths & Weaknesses
Table 153. Kedrion (Italy) Basic Information, Manufacturing Base and Competitors
Table 154. Kedrion (Italy) Major Business
Table 155. Kedrion (Italy) Antiviral Immunoglobulin Product and Services
Table 156. Kedrion (Italy) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Kedrion (Italy) Recent Developments/Updates
Table 158. Kedrion (Italy) Competitive Strengths & Weaknesses
Table 159. LFB Group (France) Basic Information, Manufacturing Base and Competitors
Table 160. LFB Group (France) Major Business
Table 161. LFB Group (France) Antiviral Immunoglobulin Product and Services
Table 162. LFB Group (France) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. LFB Group (France) Recent Developments/Updates
Table 164. LFB Group (France) Competitive Strengths & Weaknesses
Table 165. Octapharma (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 166. Octapharma (Switzerland) Major Business
Table 167. Octapharma (Switzerland) Antiviral Immunoglobulin Product and Services
Table 168. Octapharma (Switzerland) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Octapharma (Switzerland) Recent Developments/Updates
Table 170. Octapharma (Switzerland) Competitive Strengths & Weaknesses
Table 171. Regeneron (US) Basic Information, Manufacturing Base and Competitors
Table 172. Regeneron (US) Major Business
Table 173. Regeneron (US) Antiviral Immunoglobulin Product and Services
Table 174. Regeneron (US) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Regeneron (US) Recent Developments/Updates
Table 176. Regeneron (US) Competitive Strengths & Weaknesses
Table 177. Roche (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 178. Roche (Switzerland) Major Business
Table 179. Roche (Switzerland) Antiviral Immunoglobulin Product and Services
Table 180. Roche (Switzerland) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Roche (Switzerland) Recent Developments/Updates
Table 182. Roche (Switzerland) Competitive Strengths & Weaknesses
Table 183. Sanofi (France) Basic Information, Manufacturing Base and Competitors
Table 184. Sanofi (France) Major Business
Table 185. Sanofi (France) Antiviral Immunoglobulin Product and Services
Table 186. Sanofi (France) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Sanofi (France) Recent Developments/Updates
Table 188. Sanofi (France) Competitive Strengths & Weaknesses
Table 189. Shanghai RAAS (China) Basic Information, Manufacturing Base and Competitors
Table 190. Shanghai RAAS (China) Major Business
Table 191. Shanghai RAAS (China) Antiviral Immunoglobulin Product and Services
Table 192. Shanghai RAAS (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Shanghai RAAS (China) Recent Developments/Updates
Table 194. Shanghai RAAS (China) Competitive Strengths & Weaknesses
Table 195. Shuanglin Bio (China) Basic Information, Manufacturing Base and Competitors
Table 196. Shuanglin Bio (China) Major Business
Table 197. Shuanglin Bio (China) Antiviral Immunoglobulin Product and Services
Table 198. Shuanglin Bio (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Shuanglin Bio (China) Recent Developments/Updates
Table 200. Shuanglin Bio (China) Competitive Strengths & Weaknesses
Table 201. SK Plasma (S. Korea) Basic Information, Manufacturing Base and Competitors
Table 202. SK Plasma (S. Korea) Major Business
Table 203. SK Plasma (S. Korea) Antiviral Immunoglobulin Product and Services
Table 204. SK Plasma (S. Korea) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. SK Plasma (S. Korea) Recent Developments/Updates
Table 206. SK Plasma (S. Korea) Competitive Strengths & Weaknesses
Table 207. Takeda Pharmaceutical (Japan) Basic Information, Manufacturing Base and Competitors
Table 208. Takeda Pharmaceutical (Japan) Major Business
Table 209. Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Product and Services
Table 210. Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Takeda Pharmaceutical (Japan) Recent Developments/Updates
Table 212. Takeda Pharmaceutical (Japan) Competitive Strengths & Weaknesses
Table 213. Tiantan Bio (China) Basic Information, Manufacturing Base and Competitors
Table 214. Tiantan Bio (China) Major Business
Table 215. Tiantan Bio (China) Antiviral Immunoglobulin Product and Services
Table 216. Tiantan Bio (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Tiantan Bio (China) Recent Developments/Updates
Table 218. Tiantan Bio (China) Competitive Strengths & Weaknesses
Table 219. Weiguang Biological (China) Basic Information, Manufacturing Base and Competitors
Table 220. Weiguang Biological (China) Major Business
Table 221. Weiguang Biological (China) Antiviral Immunoglobulin Product and Services
Table 222. Weiguang Biological (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. Weiguang Biological (China) Recent Developments/Updates
Table 224. Weiguang Biological (China) Competitive Strengths & Weaknesses
Table 225. Yuanda Shuyang (China) Basic Information, Manufacturing Base and Competitors
Table 226. Yuanda Shuyang (China) Major Business
Table 227. Yuanda Shuyang (China) Antiviral Immunoglobulin Product and Services
Table 228. Yuanda Shuyang (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Yuanda Shuyang (China) Recent Developments/Updates
Table 230. Yuanda Shuyang (China) Competitive Strengths & Weaknesses
Table 231. Global Key Players of Antiviral Immunoglobulin Upstream (Raw Materials)
Table 232. Global Antiviral Immunoglobulin Typical Customers
Table 233. Antiviral Immunoglobulin Typical Distributors
Table 1. World Antiviral Immunoglobulin Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Antiviral Immunoglobulin Production Value by Region (2021-2026) & (USD Million)
Table 3. World Antiviral Immunoglobulin Production Value by Region (2027-2032) & (USD Million)
Table 4. World Antiviral Immunoglobulin Production Value Market Share by Region (2021-2026)
Table 5. World Antiviral Immunoglobulin Production Value Market Share by Region (2027-2032)
Table 6. World Antiviral Immunoglobulin Production by Region (2021-2026) & (kg)
Table 7. World Antiviral Immunoglobulin Production by Region (2027-2032) & (kg)
Table 8. World Antiviral Immunoglobulin Production Market Share by Region (2021-2026)
Table 9. World Antiviral Immunoglobulin Production Market Share by Region (2027-2032)
Table 10. World Antiviral Immunoglobulin Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Antiviral Immunoglobulin Average Price by Region (2027-2032) & (US$/kg)
Table 12. Antiviral Immunoglobulin Major Market Trends
Table 13. World Antiviral Immunoglobulin Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (kg)
Table 14. World Antiviral Immunoglobulin Consumption by Region (2021-2026) & (kg)
Table 15. World Antiviral Immunoglobulin Consumption Forecast by Region (2027-2032) & (kg)
Table 16. World Antiviral Immunoglobulin Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Antiviral Immunoglobulin Producers in 2025
Table 18. World Antiviral Immunoglobulin Production by Manufacturer (2021-2026) & (kg)
Table 19. Production Market Share of Key Antiviral Immunoglobulin Producers in 2025
Table 20. World Antiviral Immunoglobulin Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Antiviral Immunoglobulin Company Evaluation Quadrant
Table 22. World Antiviral Immunoglobulin Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Antiviral Immunoglobulin Production Site of Key Manufacturer
Table 24. Antiviral Immunoglobulin Market: Company Product Type Footprint
Table 25. Antiviral Immunoglobulin Market: Company Product Application Footprint
Table 26. Antiviral Immunoglobulin Competitive Factors
Table 27. Antiviral Immunoglobulin New Entrant and Capacity Expansion Plans
Table 28. Antiviral Immunoglobulin Mergers & Acquisitions Activity
Table 29. United States VS China Antiviral Immunoglobulin Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Antiviral Immunoglobulin Production Comparison, (2021 & 2025 & 2032) & (kg)
Table 31. United States VS China Antiviral Immunoglobulin Consumption Comparison, (2021 & 2025 & 2032) & (kg)
Table 32. United States Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Antiviral Immunoglobulin Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Antiviral Immunoglobulin Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Antiviral Immunoglobulin Production (2021-2026) & (kg)
Table 36. United States Based Manufacturers Antiviral Immunoglobulin Production Market Share (2021-2026)
Table 37. China Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Antiviral Immunoglobulin Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Antiviral Immunoglobulin Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Antiviral Immunoglobulin Production, (2021-2026) & (kg)
Table 41. China Based Manufacturers Antiviral Immunoglobulin Production Market Share (2021-2026)
Table 42. Rest of World Based Antiviral Immunoglobulin Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Antiviral Immunoglobulin Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Antiviral Immunoglobulin Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Antiviral Immunoglobulin Production, (2021-2026) & (kg)
Table 46. Rest of World Based Manufacturers Antiviral Immunoglobulin Production Market Share (2021-2026)
Table 47. World Antiviral Immunoglobulin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Antiviral Immunoglobulin Production by Type (2021-2026) & (kg)
Table 49. World Antiviral Immunoglobulin Production by Type (2027-2032) & (kg)
Table 50. World Antiviral Immunoglobulin Production Value by Type (2021-2026) & (USD Million)
Table 51. World Antiviral Immunoglobulin Production Value by Type (2027-2032) & (USD Million)
Table 52. World Antiviral Immunoglobulin Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Antiviral Immunoglobulin Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Antiviral Immunoglobulin Production Value by IgG Purity, (USD Million), 2021 & 2025 & 2032
Table 55. World Antiviral Immunoglobulin Production by IgG Purity (2021-2026) & (kg)
Table 56. World Antiviral Immunoglobulin Production by IgG Purity (2027-2032) & (kg)
Table 57. World Antiviral Immunoglobulin Production Value by IgG Purity (2021-2026) & (USD Million)
Table 58. World Antiviral Immunoglobulin Production Value by IgG Purity (2027-2032) & (USD Million)
Table 59. World Antiviral Immunoglobulin Average Price by IgG Purity (2021-2026) & (US$/kg)
Table 60. World Antiviral Immunoglobulin Average Price by IgG Purity (2027-2032) & (US$/kg)
Table 61. World Antiviral Immunoglobulin Production Value by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Table 62. World Antiviral Immunoglobulin Production by Therapeutic Area (2021-2026) & (kg)
Table 63. World Antiviral Immunoglobulin Production by Therapeutic Area (2027-2032) & (kg)
Table 64. World Antiviral Immunoglobulin Production Value by Therapeutic Area (2021-2026) & (USD Million)
Table 65. World Antiviral Immunoglobulin Production Value by Therapeutic Area (2027-2032) & (USD Million)
Table 66. World Antiviral Immunoglobulin Average Price by Therapeutic Area (2021-2026) & (US$/kg)
Table 67. World Antiviral Immunoglobulin Average Price by Therapeutic Area (2027-2032) & (US$/kg)
Table 68. World Antiviral Immunoglobulin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Antiviral Immunoglobulin Production by Application (2021-2026) & (kg)
Table 70. World Antiviral Immunoglobulin Production by Application (2027-2032) & (kg)
Table 71. World Antiviral Immunoglobulin Production Value by Application (2021-2026) & (USD Million)
Table 72. World Antiviral Immunoglobulin Production Value by Application (2027-2032) & (USD Million)
Table 73. World Antiviral Immunoglobulin Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Antiviral Immunoglobulin Average Price by Application (2027-2032) & (US$/kg)
Table 75. ADMA Biologics (US) Basic Information, Manufacturing Base and Competitors
Table 76. ADMA Biologics (US) Major Business
Table 77. ADMA Biologics (US) Antiviral Immunoglobulin Product and Services
Table 78. ADMA Biologics (US) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. ADMA Biologics (US) Recent Developments/Updates
Table 80. ADMA Biologics (US) Competitive Strengths & Weaknesses
Table 81. AstraZeneca (UK/Sweden) Basic Information, Manufacturing Base and Competitors
Table 82. AstraZeneca (UK/Sweden) Major Business
Table 83. AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Product and Services
Table 84. AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. AstraZeneca (UK/Sweden) Recent Developments/Updates
Table 86. AstraZeneca (UK/Sweden) Competitive Strengths & Weaknesses
Table 87. Bharat Serums & Vaccines (India) Basic Information, Manufacturing Base and Competitors
Table 88. Bharat Serums & Vaccines (India) Major Business
Table 89. Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Product and Services
Table 90. Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bharat Serums & Vaccines (India) Recent Developments/Updates
Table 92. Bharat Serums & Vaccines (India) Competitive Strengths & Weaknesses
Table 93. Biotest (Germany) Basic Information, Manufacturing Base and Competitors
Table 94. Biotest (Germany) Major Business
Table 95. Biotest (Germany) Antiviral Immunoglobulin Product and Services
Table 96. Biotest (Germany) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Biotest (Germany) Recent Developments/Updates
Table 98. Biotest (Germany) Competitive Strengths & Weaknesses
Table 99. Boya Bio (China) Basic Information, Manufacturing Base and Competitors
Table 100. Boya Bio (China) Major Business
Table 101. Boya Bio (China) Antiviral Immunoglobulin Product and Services
Table 102. Boya Bio (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Boya Bio (China) Recent Developments/Updates
Table 104. Boya Bio (China) Competitive Strengths & Weaknesses
Table 105. China Biologic Products (CNBG) (China) Basic Information, Manufacturing Base and Competitors
Table 106. China Biologic Products (CNBG) (China) Major Business
Table 107. China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Product and Services
Table 108. China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. China Biologic Products (CNBG) (China) Recent Developments/Updates
Table 110. China Biologic Products (CNBG) (China) Competitive Strengths & Weaknesses
Table 111. CSL Behring (US/Germany) Basic Information, Manufacturing Base and Competitors
Table 112. CSL Behring (US/Germany) Major Business
Table 113. CSL Behring (US/Germany) Antiviral Immunoglobulin Product and Services
Table 114. CSL Behring (US/Germany) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. CSL Behring (US/Germany) Recent Developments/Updates
Table 116. CSL Behring (US/Germany) Competitive Strengths & Weaknesses
Table 117. Emergent BioSolutions (US) Basic Information, Manufacturing Base and Competitors
Table 118. Emergent BioSolutions (US) Major Business
Table 119. Emergent BioSolutions (US) Antiviral Immunoglobulin Product and Services
Table 120. Emergent BioSolutions (US) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Emergent BioSolutions (US) Recent Developments/Updates
Table 122. Emergent BioSolutions (US) Competitive Strengths & Weaknesses
Table 123. GC Pharma (S. Korea) Basic Information, Manufacturing Base and Competitors
Table 124. GC Pharma (S. Korea) Major Business
Table 125. GC Pharma (S. Korea) Antiviral Immunoglobulin Product and Services
Table 126. GC Pharma (S. Korea) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. GC Pharma (S. Korea) Recent Developments/Updates
Table 128. GC Pharma (S. Korea) Competitive Strengths & Weaknesses
Table 129. Grifols (Spain) Basic Information, Manufacturing Base and Competitors
Table 130. Grifols (Spain) Major Business
Table 131. Grifols (Spain) Antiviral Immunoglobulin Product and Services
Table 132. Grifols (Spain) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Grifols (Spain) Recent Developments/Updates
Table 134. Grifols (Spain) Competitive Strengths & Weaknesses
Table 135. Hualan Biological (China) Basic Information, Manufacturing Base and Competitors
Table 136. Hualan Biological (China) Major Business
Table 137. Hualan Biological (China) Antiviral Immunoglobulin Product and Services
Table 138. Hualan Biological (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Hualan Biological (China) Recent Developments/Updates
Table 140. Hualan Biological (China) Competitive Strengths & Weaknesses
Table 141. Intas Pharmaceuticals (India) Basic Information, Manufacturing Base and Competitors
Table 142. Intas Pharmaceuticals (India) Major Business
Table 143. Intas Pharmaceuticals (India) Antiviral Immunoglobulin Product and Services
Table 144. Intas Pharmaceuticals (India) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Intas Pharmaceuticals (India) Recent Developments/Updates
Table 146. Intas Pharmaceuticals (India) Competitive Strengths & Weaknesses
Table 147. Kamada (Israel) Basic Information, Manufacturing Base and Competitors
Table 148. Kamada (Israel) Major Business
Table 149. Kamada (Israel) Antiviral Immunoglobulin Product and Services
Table 150. Kamada (Israel) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Kamada (Israel) Recent Developments/Updates
Table 152. Kamada (Israel) Competitive Strengths & Weaknesses
Table 153. Kedrion (Italy) Basic Information, Manufacturing Base and Competitors
Table 154. Kedrion (Italy) Major Business
Table 155. Kedrion (Italy) Antiviral Immunoglobulin Product and Services
Table 156. Kedrion (Italy) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Kedrion (Italy) Recent Developments/Updates
Table 158. Kedrion (Italy) Competitive Strengths & Weaknesses
Table 159. LFB Group (France) Basic Information, Manufacturing Base and Competitors
Table 160. LFB Group (France) Major Business
Table 161. LFB Group (France) Antiviral Immunoglobulin Product and Services
Table 162. LFB Group (France) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. LFB Group (France) Recent Developments/Updates
Table 164. LFB Group (France) Competitive Strengths & Weaknesses
Table 165. Octapharma (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 166. Octapharma (Switzerland) Major Business
Table 167. Octapharma (Switzerland) Antiviral Immunoglobulin Product and Services
Table 168. Octapharma (Switzerland) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Octapharma (Switzerland) Recent Developments/Updates
Table 170. Octapharma (Switzerland) Competitive Strengths & Weaknesses
Table 171. Regeneron (US) Basic Information, Manufacturing Base and Competitors
Table 172. Regeneron (US) Major Business
Table 173. Regeneron (US) Antiviral Immunoglobulin Product and Services
Table 174. Regeneron (US) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Regeneron (US) Recent Developments/Updates
Table 176. Regeneron (US) Competitive Strengths & Weaknesses
Table 177. Roche (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 178. Roche (Switzerland) Major Business
Table 179. Roche (Switzerland) Antiviral Immunoglobulin Product and Services
Table 180. Roche (Switzerland) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Roche (Switzerland) Recent Developments/Updates
Table 182. Roche (Switzerland) Competitive Strengths & Weaknesses
Table 183. Sanofi (France) Basic Information, Manufacturing Base and Competitors
Table 184. Sanofi (France) Major Business
Table 185. Sanofi (France) Antiviral Immunoglobulin Product and Services
Table 186. Sanofi (France) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Sanofi (France) Recent Developments/Updates
Table 188. Sanofi (France) Competitive Strengths & Weaknesses
Table 189. Shanghai RAAS (China) Basic Information, Manufacturing Base and Competitors
Table 190. Shanghai RAAS (China) Major Business
Table 191. Shanghai RAAS (China) Antiviral Immunoglobulin Product and Services
Table 192. Shanghai RAAS (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Shanghai RAAS (China) Recent Developments/Updates
Table 194. Shanghai RAAS (China) Competitive Strengths & Weaknesses
Table 195. Shuanglin Bio (China) Basic Information, Manufacturing Base and Competitors
Table 196. Shuanglin Bio (China) Major Business
Table 197. Shuanglin Bio (China) Antiviral Immunoglobulin Product and Services
Table 198. Shuanglin Bio (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. Shuanglin Bio (China) Recent Developments/Updates
Table 200. Shuanglin Bio (China) Competitive Strengths & Weaknesses
Table 201. SK Plasma (S. Korea) Basic Information, Manufacturing Base and Competitors
Table 202. SK Plasma (S. Korea) Major Business
Table 203. SK Plasma (S. Korea) Antiviral Immunoglobulin Product and Services
Table 204. SK Plasma (S. Korea) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. SK Plasma (S. Korea) Recent Developments/Updates
Table 206. SK Plasma (S. Korea) Competitive Strengths & Weaknesses
Table 207. Takeda Pharmaceutical (Japan) Basic Information, Manufacturing Base and Competitors
Table 208. Takeda Pharmaceutical (Japan) Major Business
Table 209. Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Product and Services
Table 210. Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Takeda Pharmaceutical (Japan) Recent Developments/Updates
Table 212. Takeda Pharmaceutical (Japan) Competitive Strengths & Weaknesses
Table 213. Tiantan Bio (China) Basic Information, Manufacturing Base and Competitors
Table 214. Tiantan Bio (China) Major Business
Table 215. Tiantan Bio (China) Antiviral Immunoglobulin Product and Services
Table 216. Tiantan Bio (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. Tiantan Bio (China) Recent Developments/Updates
Table 218. Tiantan Bio (China) Competitive Strengths & Weaknesses
Table 219. Weiguang Biological (China) Basic Information, Manufacturing Base and Competitors
Table 220. Weiguang Biological (China) Major Business
Table 221. Weiguang Biological (China) Antiviral Immunoglobulin Product and Services
Table 222. Weiguang Biological (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. Weiguang Biological (China) Recent Developments/Updates
Table 224. Weiguang Biological (China) Competitive Strengths & Weaknesses
Table 225. Yuanda Shuyang (China) Basic Information, Manufacturing Base and Competitors
Table 226. Yuanda Shuyang (China) Major Business
Table 227. Yuanda Shuyang (China) Antiviral Immunoglobulin Product and Services
Table 228. Yuanda Shuyang (China) Antiviral Immunoglobulin Production (kg), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Yuanda Shuyang (China) Recent Developments/Updates
Table 230. Yuanda Shuyang (China) Competitive Strengths & Weaknesses
Table 231. Global Key Players of Antiviral Immunoglobulin Upstream (Raw Materials)
Table 232. Global Antiviral Immunoglobulin Typical Customers
Table 233. Antiviral Immunoglobulin Typical Distributors
LIST OF FIGURES
Figure 1. Antiviral Immunoglobulin Picture
Figure 2. World Antiviral Immunoglobulin Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Antiviral Immunoglobulin Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 5. World Antiviral Immunoglobulin Average Price (2021-2032) & (US$/kg)
Figure 6. World Antiviral Immunoglobulin Production Value Market Share by Region (2021-2032)
Figure 7. World Antiviral Immunoglobulin Production Market Share by Region (2021-2032)
Figure 8. North America Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 9. Europe Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 10. China Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 11. Japan Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 12. India Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 13. Antiviral Immunoglobulin Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 16. World Antiviral Immunoglobulin Consumption Market Share by Region (2021-2032)
Figure 17. United States Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 18. China Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 19. Europe Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 20. Japan Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 21. South Korea Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 22. ASEAN Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 23. India Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 24. Producer Shipments of Antiviral Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antiviral Immunoglobulin Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antiviral Immunoglobulin Markets in 2025
Figure 27. United States VS China: Antiviral Immunoglobulin Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Antiviral Immunoglobulin Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Antiviral Immunoglobulin Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Antiviral Immunoglobulin Production Market Share 2025
Figure 31. China Based Manufacturers Antiviral Immunoglobulin Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Antiviral Immunoglobulin Production Market Share 2025
Figure 33. World Antiviral Immunoglobulin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Antiviral Immunoglobulin Production Value Market Share by Type in 2025
Figure 35. Human Plasma Derived Polyclonal
Figure 36. Hyperimmune Specific Globulin
Figure 37. Recombinant Monoclonal Antibody (mAb)
Figure 38. Animal Derived (Equine/Ovine)
Figure 39. Others
Figure 40. World Antiviral Immunoglobulin Production Market Share by Type (2021-2032)
Figure 41. World Antiviral Immunoglobulin Production Value Market Share by Type (2021-2032)
Figure 42. World Antiviral Immunoglobulin Average Price by Type (2021-2032) & (US$/kg)
Figure 43. World Antiviral Immunoglobulin Production Value by IgG Purity, (USD Million), 2021 & 2025 & 2032
Figure 44. World Antiviral Immunoglobulin Production Value Market Share by IgG Purity in 2025
Figure 45. Standard Fractionated Grade (90%–95%)
Figure 46. Clinical High Purity Grade (96%–98%)
Figure 47. Ultra Purified Specialty Grade(99%)
Figure 48. World Antiviral Immunoglobulin Production Market Share by IgG Purity (2021-2032)
Figure 49. World Antiviral Immunoglobulin Production Value Market Share by IgG Purity (2021-2032)
Figure 50. World Antiviral Immunoglobulin Average Price by IgG Purity (2021-2032) & (US$/kg)
Figure 51. World Antiviral Immunoglobulin Production Value by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Figure 52. World Antiviral Immunoglobulin Production Value Market Share by Therapeutic Area in 2025
Figure 53. Transplantation
Figure 54. Infectious Disease Prophylaxis
Figure 55. Immunodeficiency
Figure 56. Neurology (Autoimmune)
Figure 57. Others
Figure 58. World Antiviral Immunoglobulin Production Market Share by Therapeutic Area (2021-2032)
Figure 59. World Antiviral Immunoglobulin Production Value Market Share by Therapeutic Area (2021-2032)
Figure 60. World Antiviral Immunoglobulin Average Price by Therapeutic Area (2021-2032) & (US$/kg)
Figure 61. World Antiviral Immunoglobulin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Antiviral Immunoglobulin Production Value Market Share by Application in 2025
Figure 63. Hospitals
Figure 64. Specialty Clinics
Figure 65. Home Care
Figure 66. Others
Figure 67. World Antiviral Immunoglobulin Production Market Share by Application (2021-2032)
Figure 68. World Antiviral Immunoglobulin Production Value Market Share by Application (2021-2032)
Figure 69. World Antiviral Immunoglobulin Average Price by Application (2021-2032) & (US$/kg)
Figure 70. Antiviral Immunoglobulin Industry Chain
Figure 71. Antiviral Immunoglobulin Procurement Model
Figure 72. Antiviral Immunoglobulin Sales Model
Figure 73. Antiviral Immunoglobulin Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
Figure 1. Antiviral Immunoglobulin Picture
Figure 2. World Antiviral Immunoglobulin Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Antiviral Immunoglobulin Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 5. World Antiviral Immunoglobulin Average Price (2021-2032) & (US$/kg)
Figure 6. World Antiviral Immunoglobulin Production Value Market Share by Region (2021-2032)
Figure 7. World Antiviral Immunoglobulin Production Market Share by Region (2021-2032)
Figure 8. North America Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 9. Europe Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 10. China Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 11. Japan Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 12. India Antiviral Immunoglobulin Production (2021-2032) & (kg)
Figure 13. Antiviral Immunoglobulin Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 16. World Antiviral Immunoglobulin Consumption Market Share by Region (2021-2032)
Figure 17. United States Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 18. China Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 19. Europe Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 20. Japan Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 21. South Korea Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 22. ASEAN Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 23. India Antiviral Immunoglobulin Consumption (2021-2032) & (kg)
Figure 24. Producer Shipments of Antiviral Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antiviral Immunoglobulin Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antiviral Immunoglobulin Markets in 2025
Figure 27. United States VS China: Antiviral Immunoglobulin Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Antiviral Immunoglobulin Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Antiviral Immunoglobulin Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Antiviral Immunoglobulin Production Market Share 2025
Figure 31. China Based Manufacturers Antiviral Immunoglobulin Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Antiviral Immunoglobulin Production Market Share 2025
Figure 33. World Antiviral Immunoglobulin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Antiviral Immunoglobulin Production Value Market Share by Type in 2025
Figure 35. Human Plasma Derived Polyclonal
Figure 36. Hyperimmune Specific Globulin
Figure 37. Recombinant Monoclonal Antibody (mAb)
Figure 38. Animal Derived (Equine/Ovine)
Figure 39. Others
Figure 40. World Antiviral Immunoglobulin Production Market Share by Type (2021-2032)
Figure 41. World Antiviral Immunoglobulin Production Value Market Share by Type (2021-2032)
Figure 42. World Antiviral Immunoglobulin Average Price by Type (2021-2032) & (US$/kg)
Figure 43. World Antiviral Immunoglobulin Production Value by IgG Purity, (USD Million), 2021 & 2025 & 2032
Figure 44. World Antiviral Immunoglobulin Production Value Market Share by IgG Purity in 2025
Figure 45. Standard Fractionated Grade (90%–95%)
Figure 46. Clinical High Purity Grade (96%–98%)
Figure 47. Ultra Purified Specialty Grade(99%)
Figure 48. World Antiviral Immunoglobulin Production Market Share by IgG Purity (2021-2032)
Figure 49. World Antiviral Immunoglobulin Production Value Market Share by IgG Purity (2021-2032)
Figure 50. World Antiviral Immunoglobulin Average Price by IgG Purity (2021-2032) & (US$/kg)
Figure 51. World Antiviral Immunoglobulin Production Value by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Figure 52. World Antiviral Immunoglobulin Production Value Market Share by Therapeutic Area in 2025
Figure 53. Transplantation
Figure 54. Infectious Disease Prophylaxis
Figure 55. Immunodeficiency
Figure 56. Neurology (Autoimmune)
Figure 57. Others
Figure 58. World Antiviral Immunoglobulin Production Market Share by Therapeutic Area (2021-2032)
Figure 59. World Antiviral Immunoglobulin Production Value Market Share by Therapeutic Area (2021-2032)
Figure 60. World Antiviral Immunoglobulin Average Price by Therapeutic Area (2021-2032) & (US$/kg)
Figure 61. World Antiviral Immunoglobulin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 62. World Antiviral Immunoglobulin Production Value Market Share by Application in 2025
Figure 63. Hospitals
Figure 64. Specialty Clinics
Figure 65. Home Care
Figure 66. Others
Figure 67. World Antiviral Immunoglobulin Production Market Share by Application (2021-2032)
Figure 68. World Antiviral Immunoglobulin Production Value Market Share by Application (2021-2032)
Figure 69. World Antiviral Immunoglobulin Average Price by Application (2021-2032) & (US$/kg)
Figure 70. Antiviral Immunoglobulin Industry Chain
Figure 71. Antiviral Immunoglobulin Procurement Model
Figure 72. Antiviral Immunoglobulin Sales Model
Figure 73. Antiviral Immunoglobulin Sales Channels, Direct Sales, and Distribution
Figure 74. Methodology
Figure 75. Research Process and Data Source
